Edition:
United States

Sol Gel Technologies Ltd (SLGL.OQ)

SLGL.OQ on NASDAQ Stock Exchange Global Market

9.65USD
4:00pm EDT
Change (% chg)

$0.48 (+5.23%)
Prev Close
$9.17
Open
$9.37
Day's High
$9.65
Day's Low
$9.37
Volume
257
Avg. Vol
--
52-wk High
$16.47
52-wk Low
$7.39

Chart for

About

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary,... (more)

Overall

Beta: --
Market Cap(Mil.): $181.73
Shares Outstanding(Mil.): 18.95
Dividend: --
Yield (%): --

Financials

  SLGL.OQ Industry Sector
P/E (TTM): -- 243.17 32.94
EPS (TTM): -1.84 -- --
ROI: -- -7.30 12.79
ROE: -- -10.05 14.67

BRIEF-Sol-Gel Technologies Reported Loss Of $5.7 Million For Q1

* SOL-GEL TECHNOLOGIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 15 2018

BRIEF-Sol-Gel Technologies Reports Q4 Loss Of $5.5 Mln Vs. Loss Of $4.9 Mln A Year Earlier

* SOL-GEL TECHNOLOGIES REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 26 2018

BRIEF-Sol-Gel Technologies Announces Pricing Of IPO

* ‍PRICING OF ITS INITIAL PUBLIC OFFERING OF 6.3 MILLION ORDINARY SHARES AT A PUBLIC OFFERING PRICE OF $12.00 PER ORDINARY SHARE​ Source text for Eikon: Further company coverage:

Jan 31 2018

BRIEF-Sol Gel Technologies Sees IPO Of 5 Mln Ordinary Shares

* SOL GEL TECHNOLOGIES LTD SEES IPO OF 5.0 MILLION ORDINARY SHARES PRICED BETWEEN $11.00 AND $13.00 PER ORDINARY SHARE - SEC FILING

Jan 23 2018

Earnings vs. Estimates